AGN trading green + presentations from Wonderland Miami Check out AGN's presentations from Wonderland Miami from last week:
Business Presentation: https://algernonpharmaceuticals.com/wp-content/uploads/2018/01/Wonderland-Algernon-Christopher-Moreau-Business-Keynote-PPT-FINAL-For-Nov-4th.pdf
Science Presentation: https://algernonpharmaceuticals.com/wp-content/uploads/2018/01/Wonderland-Algernon-Christopher-Moreau-Science-Keynote-PPT-FINAL-For-Nov-5th.pdf
AGN has broken down its presentations into the business aspect and science aspect for a more in-depth look into both.
As the leading sponsor, Wonderland was a significant exposure opportunity for AGN, especially given they are the first company globally to investigate DMT as a possible treatment for stroke.
The positive preclinical data that is driving AGN's Phase I clinical study of DMT for the treatment of stroke was reviewed during the presentations by AGN CEO Christopher Moreau and Dr. Rick Strassman, author of "DMT: The Spirit Molecule" and AGN consultant.